1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Loncastuximab Tesirine and Epcoritamab: new trials by email Literature Review of Loncastuximab Tesirine and Epcoritamab trials Research Report on Loncastuximab Tesirine and Epcoritamab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) Loncastuximab Tesirine and Epcoritamab - Aggressive Diffuse Large B-cell Lymphoma, High-grade B-cell Lymphoma (HGBL) | Phase 2 | Recruiting | Universität Münster | 120 | 2025-10-31 | 2026-07-30 |
Lymphoma, Follicular (1) · Lymphoma, Large B-Cell, Diffuse (1)
Germany (1)
2023 (1)